DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 22 filers reported holding DIREXION SHS ETF TR in Q1 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | -15.0% | 202 | +0.5% | 0.01% | 0.0% |
| Q2 2022 | $20,000 | -23.1% | 201 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $26,000 | -55.2% | 201 | -49.9% | 0.01% | -53.8% |
| Q4 2021 | $58,000 | +34.9% | 401 | 0.0% | 0.01% | +18.2% |
| Q3 2021 | $43,000 | +4.9% | 401 | 0.0% | 0.01% | +10.0% |
| Q2 2021 | $41,000 | +20.6% | 401 | 0.0% | 0.01% | +11.1% |
| Q1 2021 | $34,000 | -12.8% | 401 | -20.0% | 0.01% | -25.0% |
| Q4 2020 | $39,000 | +56.0% | 501 | +24.9% | 0.01% | +33.3% |
| Q3 2020 | $25,000 | -78.1% | 401 | -80.6% | 0.01% | -79.1% |
| Q2 2020 | $114,000 | +123.5% | 2,065 | +41.0% | 0.04% | +79.2% |
| Q1 2020 | $51,000 | -40.7% | 1,465 | +26.0% | 0.02% | -17.2% |
| Q4 2019 | $86,000 | -29.5% | 1,163 | -53.3% | 0.03% | -34.1% |
| Q3 2019 | $122,000 | +93.7% | 2,488 | +122.1% | 0.04% | +83.3% |
| Q2 2019 | $63,000 | – | 1,120 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 55,597 | $2,523,000 | 0.14% |
| Traynor Capital Management, Inc. | 7,481 | $341,000 | 0.12% |
| Virtu Financial LLC | 49,149 | $2,230,000 | 0.10% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 2,436 | $111,000 | 0.08% |
| Capital Analysts, LLC | 6,000 | $272,000 | 0.03% |
| Acorn Wealth Advisors, LLC | 395 | $18,000 | 0.02% |
| BANQUE PICTET & CIE SA | 10,120 | $459,000 | 0.01% |
| Citadel Advisors | 78,471 | $3,560,000 | 0.00% |
| WOLVERINE TRADING, LLC | 22,300 | $960,000 | 0.00% |
| JANE STREET GROUP, LLC | 21,346 | $968,000 | 0.00% |